PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
8.16%
Net income growth under 50% of MRVL's 106.80%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-4.22%
Both reduce yoy D&A, with MRVL at -10.90%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
66.40%
Lower deferred tax growth vs. MRVL's 150.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-14.29%
Negative yoy SBC while MRVL is 3.03%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
1.48%
Slight usage while MRVL is negative at -133.98%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
269.39%
AR growth well above MRVL's 56.63%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-73.53%
Negative yoy inventory while MRVL is 76.25%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
555.56%
A yoy AP increase while MRVL is negative at -11.62%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-89.35%
Both reduce yoy usage, with MRVL at -372.68%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-2485.71%
Both negative yoy, with MRVL at -52.62%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-1.84%
Both yoy CFO lines are negative, with MRVL at -19.95%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
20.86%
Lower CapEx growth vs. MRVL's 45.38%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-20.86%
Negative yoy acquisition while MRVL stands at 8.46%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-36.20%
Negative yoy purchasing while MRVL stands at 62.31%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
48.54%
1.25-1.5x MRVL's 33.92%. Bruce Berkowitz sees a sizable advantage unless competitor’s portfolio yields future gains.
15.71%
Less 'other investing' outflow yoy vs. MRVL's 3321.48%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-13.60%
We reduce yoy invests while MRVL stands at 11989.07%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-107.79%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
5.00%
Buyback growth below 50% of MRVL's 99.26%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.